Physician profile
Emmy Thai
NPI 1558953661
$2,030.05
in general payments reported to CMS, 2019-2025
7 companies · $698 in 2025
The $698 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $320 · 2023: $444 · 2024: $317 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,459.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $773.63 | 2021-2025 | Total30, Eysuvis, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $397.47 | 2022-2025 | Infuse, Xiidra, Miebo |
| Coopervision INC. | $389.71 | 2023-2025 | Cvi Contact Lens, Myday Contact Lens, Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $212.87 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $130.99 | 2024 | Acuvue |
| Glaukos Corporation | $105.13 | 2022-2023 | Idose Tr |
| Rxsight INC | $20.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmy Thai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.